Nail fungal infections are known to be very common conditions, especially in the aging population.
However, bacterial infections and skin disorders can mimic the fungal presentation and may lead clinicians to choose ineffective treatment regimens.
The diagnosis of nail infections can take up to 3-4 weeks with conventional techniques and the treatment protocols are complicated, costly and carry risks. A patient’s quality of life is negatively impacted for most individuals, and particular subsets of the population with diabetes and immunocompromised systems can experience significant complications leading to secondary infections and amputations.
The utilization of advanced molecular PCR technology has proven to be more sensitive and specific than culture results and can help clinicians rapidly identify the causative agent(s) before developing a treatment plan.1
1 Emam Sherin M. & Osama H. Abd El-salam (2016). Real-time PCR: A rapid and sensitive method fordiagnosis of dermatophyte induced onychomycosis,a comparative study. Alexandria Journal of Medicine, Vol. 52, 83-90
Clinical Solution
KorPath™ offers the clinician access to the most advanced molecular methodology for pathogen detection, semi-quantification, and resistance gene identification. KorPath™ delivers rapid and precise results accompanied by PharmD guidance that considers published sensitivity and susceptibility patterns, medication costs, antibiotic spectrum of activity, and FDA guidance.
The end product is a patient-centered, value-based care solution that enables providers to make informed treatment decisions that could avoid inappropriate therapy, excess costs, adverse drug events and the progression of disease.
Clinical Advantages
- Prevents Delays in Diagnosis & Treatment (*24 hrs. Post Lab Arrival)
- Detects Polymicrobial Infections Simultaneously
- Identifies 49 Antibiotic Resistance Genes
- Unaffected by Concurrent Medications
- Reduces Unnecessary Drug Exposure and Adverse Events
- Decreases the Progression and Spread of Infection
- Improves Selection of Narrow-Spectrum Antibiotics
- Prepares Clinicians to Make Cost-Sensitive Treatment Decisions
* Test results could be delayed in some circumstances when there is error in clerical documentation, collections, lab handling, or a delay in shipping.
KorPath
3110 Cherry Palm Drive
Suite 340
Tampa, FL 33619
1 (800) 442-1304
info@korpath.com
CLIA #10D0699501